Prudential Financial Inc Fulcrum Therapeutics, Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$2.51 - $7.38 $20,544 - $60,405	-8,185 Reduced 36.02%	14,540 $100,000
Q1 2025 May 13, 2025	BUY	$2.88 - $5.08 $144 - $254	50 Added 0.22%	22,725 $65,000
Q3 2024 Nov 13, 2024	BUY	$3.18 - $9.74 $72,106 - $220,854	22,675 New	22,675 $80,000
Q1 2022 May 13, 2022	SELL	$9.96 - $23.65 $286,549 - $680,410	-28,770 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $402,780 - $818,218	28,770 New	28,770 $509,000

135

55.4M

176K

13.5K

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $451M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.